A collection of disease information resources and questions answered by our genetic and rare diseases information specialists for glycogen storage disease. An autosomal recessive disease in which gene expression of glucose6phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Glycogen storage disease type iii eugene australia. The accumulated glycogen is structurally abnormal and impairs the function of certain organs and tissues, especially the liver and muscles. Test glycogen storage disease and disorders of glucose. This may include adaptations for participation, such as driving modification if. Glycogen storage disease type iii nord national organization. Glycogen storage disease type ia gsd ia is an inherited disorder caused by the deficiency of an enzyme called glucose6phosphastase that prevents the body from completely breaking down food into energy. Glycogen storage disease type iii is an autosomal recessive metabolic disorder and inborn error of metabolism specifically of carbohydrates characterized by a. This enzyme is composed of two independent catalytic subunits on one polypeptide. The main types of glycogen storage diseases in children are categorized by number and name. Glycogen storage disease type iii gsd type iii is an autosomal recessive condition due to deficiency of the glycogen debranching enzyme. When these patients are subjected to anesthesia, perioperative complications can develop, including hypoglycemia, rhabdomyolysis, myoglobinuria, acute renal failure, and postoperative fatigue.
Glycogen storage diseases are rare genetic disorders of glycogen synthesis, degradation, or metabolism regulation. This enzyme is composed of two independent catalytic subunits on one polypeptide chain, oligo1,41,4 glucantransferase and amylo1,6glucosidase. Type i glycogen storage disease is associated with abnormalities in two genes. Glycogen storage disease type i genetics home reference. Glycogen storage disease type 3 gsdiii is an inherited disorder caused by. The disease results from a pan deficiency of the enzyme gsd 3a and musclespecific retention of glycogen debranching enzyme gsd 3b. Glycogen storage disease type 3 includes different forms. To identify complications amenable to prevention in adults with glycogen storage disease gsd types ia, ib, and iii and to determine the effect of the disease on social factors.
Visser g, rake jp, kokke ft, nikkels pg, sauer pj, smit gp. Gsd iiib, with liver involvement only, comprises about 15% of all gsd iii. Clinical features at presentation typically include hepatomegaly, hyperlacticacidemia, and. Glycogen storage disease type iii gsd iii is characterized by variable liver, cardiac muscle, and skeletal muscle involvement. The severity of this disease varies on the amount of enzyme produced. Molecular diagnosis of glycogen storage disease type i. Mutations in the g6pc gene result in a deficiency in the glucose6phosphatase g6pase enzyme and account for approximately 80% of gsdi. Glycogen storage disease type iii also known as gsdiii or cori disease is an inherited disorder caused by the buildup of a complex sugar called glycogen in the bodys cells. Glycogen storage disease gsd is a genetic condition in which the body has an enzyme problem and is not able to store or break down the complex sugar glycogen properly.
Glycogen storage disorder type 1a glycogen storage disease type 1a is a condition characterized by abnormally low blood sugar levels, enlarged liver and kidneys, and impaired growth that results from the buildup of stored glycogen in the body. Gsd i causes the inability of the liver to breakdown glycogen to glucose which the body uses as its main source of fuel. Glycogen storage disease type iv gsd type iv is an extremely rare condition, representing only 0. Glycogen storage disease type 3 genetic and rare diseases nih. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. If not properly managed, glucose will build to high levels after a meal because your body is unable to store it as glycogen but, once that glucose is used up, you will develop hypoglycaemia or low levels of. There are a number of different enzymes involved in glycogen synthesis, utilisation and breakdown within the body. Gsd affects the liver, muscles and other areas of the body. Glycogen is stored primarily in skeletal muscle and liver as a critical source of energyin skeletal muscle as a fuel for muscle contraction, in liver as a source of glucose for extrahepatic metabolism.
In between meals also called fasting, our bodies turn the glycogen into glucose to give us energy. Glycogen storage disease type 5 gsd5, also known as myophosphorylase deficiency or mcardles disease, is a rare inherited metabolic disorder, characterized by exercise intolerance. Affected individuals exhibit growth retardation, delayed puberty, lactic acidemia, hyperlipidemia, hyperuricemia, and in adults a high incidence of. Glycogen storage disease type iii is known as an autosomal recessive condition. Gsd iiia is the most common subtype, present in about 85% of affected individuals. Glycogen storage disease type iii is a rare disease of variable clinical. Typically, our bodies store extra energy from our food as glycogen. Intestinal function in glycogen storage disease type i. Mutations in the slc37a4 gene result in a deficiency in the glucose6phosphatase translocase enzyme transporter.
Glycogen storage disease type 3 gsdiii is an inherited disorder caused by the buildup of glycogen in the bodys cells. The highest incidence of glycogen storage disease type iii is in the faroe islands where it occurs in 1 out of every 3,600 births, probably due to a founder effect. Glycogen storage disease gsd is a rare condition that changes the way the body uses and stores glycogen, a form of sugar or glucose. These disorders are found in all ethnic groups, but founder pathogenic variants may put certain populations at higher risk for example, gsd type iii in the faroe. Also called pompe disease deficiency of lysosomal acid. Glycogen storage diseases gsds type i gsdi and type iii gsdiii, the most frequent hepatic gsds, are due to defects in glycogen. This buildup impairs the function of certain organs and tissues, especially the liver and muscles. If you have gsd type 0, you are unable to build up your glycogen stores in the first place. A glycogen storage disease gsd results from the absence of enzymes that ultimately convert glycogen compounds to glucose.
Glycogen storage disease type ix also known as gsd ix is a condition caused by the inability to break down a complex sugar called glycogen. This means that they are healthy because they also have a working copy of the gene. General nutrition guidelines for glycogen storage disease type i glycogen storage disease type i gsdi is a genetic metabolic disorder of the liver. In both tissues, glycogen metabolism is achieved by the. People with gsd have trouble synthesizing and breaking down glucose, which can cause a laundry list of health issues, including chronic low. Glycogen storage disease type iii is a rare disease of variable clinical severity affecting primarily the liver, heart, and skeletal muscle. A lack of glycogen breakdown interferes with the normal function of the affected tissue. Glycogen storage disease radiology reference article.
Glycogen storage disease type iii diagnosis and management. Glycogen is a very large molecule and cannot pass through cell walls. Gene testing to look for problems with the genes for different enzymes. Glycogen storage disease type 2, also known as pompe disease or acid. Glycogen itself is not released from the liver into the body. Diagnosis of glycogen storage disease type i is delayed in brazil. When the body needs more energy, certain proteins called enzymes break down glycogen into glucose. In the case of gsdv, symptoms are caused by the lack of the enzyme muscle phosphorylase myophosphorylase. Does glycogen store in any other organs than liver with glucose6phosphatase deficiency type i. Type i glycogen storage disease gsd i is a disorder of glucose production. Diagnosis and management of glycogen storage disease type. Glycogen storage disease type ii accessed 27 october 2017 infantile form.
Glycogen storage disease type v mcardle disease or gsdv is one of several inherited glycogen storage diseases all of which are caused by failures of specific enzymes required for the storage of energysupplying glycogen. Glucose6phosphatase deficiency is also known as hepatorenal glycogen storage disease. Glycogen storage disease type iii also known as gsdiii or cori disease is an inherited disorder caused by the buildup of a complex sugar. Glycogen storage disease type iii genetics home reference nih. Glycogen storage disease type iv is autosomal recessive, which means each parent has a mutant copy of the gene but show no symptoms of the disease.
Conversion is usually a oneway reaction from glycogen into glucose1,6 phosphate 4. Glycogen storage disease gsd refers to a number of syndromes which are characterized by a defect in synthesis, metabolism or storage of glycogen pathology. The accumulation of glycogen in certain organs and tissues, especially the liver, kidneys, and small intestines, impairs their ability to function normally. Glycogen storage disease gsd is a rare genetic disorder that affects about one in 20,000 people in the u. A glycogen storage disease gsd, also glycogenosis and dextrinosis is a metabolic disorder caused by enzyme deficiencies affecting either glycogen synthesis, glycogen breakdown or glycolysis glucose breakdown, typically in muscles andor liver cells.
Due to a missing or impaired enzyme, the body is unable to maintain normal blood sugar levels between meals. The different forms of the condition can affect glycogen breakdown in liver cells or muscle cells or sometimes both. Glycogen storage disease type i radiology reference. Glycogen is a branchedchain polymer of glucose and serves as a dynamic but limited reservoir of glucose, mainly in liver, skeletal muscle, heart, and sometimes the central nervous system and the kidneys. Pediatric glycogen storage disease childrens pittsburgh. Glycogen storage disease type iii, or gsd iii, is a genetic condition where your body cannot break down glycogen into glucose for energy. This type of gsdi is termed glycogen storage disease type ia. It is caused by deficient activity of the glucose 6phosphatase enzyme gsd ia or a deficiency in the microsomal transport proteins for glucose 6phosphate gsd ib, resulting in excessive accumulation. Glycogen storage disease in adults annals of internal. It presents during the first year of life, usually with symptomatic hypoglycemia when an infants feeding interval is increased or normal feeding is disrupted by acute illness. Glycogen storage disease type i gsd i is a relatively rare metabolic disease with variable clinical intensity.
It is clinically characterized by hepatomegaly, hypoglycemia, short stature, and variable myopathy. Read more about symptoms, diagnosis, treatment, complications, causes and prognosis. Glycogen is a highly branched glucose polymer consisting of chains of. Referral medical centers in the united states and canada. Challenges of gene therapy for the treatment of glycogen storage. Glycogen storage disease type i gsd i is a rare disease of variable clinical severity that primarily affects the liver and kidney. The objective of this study was to describe the perioperative course of a cohort. Type i glycogen storage disease symptoms, diagnosis and. It is caused by deficient activity of the glucose 6phosphatase enzyme gsd ia or a deficiency in the microsomal transport proteins for glucose 6phosphate gsd ib. It is an inherited disorder that affects the metabolism the way the body breaks food down into energy.
165 1326 1556 323 1011 649 650 1359 1226 1140 1051 1178 627 352 646 1344 888 1154 1674 1471 1487 527 27 1213 152 1361 910